Dr. Faiza Naseer

Dr. Faiza Naseer is a Registered Pharmacist and academic leader with over 15 years of professional experience across pharmacy practice, molecular pharmacology, higher education, and scientific research. She holds a Ph.D. in Applied Biosciences from NUST. Currently, she serves as the Head of Department of Biosciences and Assistant Professor at Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University. Her research portfolio spans targeted nanomedicine, oncolytic virotherapy, cancer therapeutics, and pharmacology, boasting a cumulative impact factor exceeding 300 along with multiple book chapters and postgraduate thesis supervisions.

EDUCATIONAL QUALIFICATIONS

ACADEMIC & PROFESSIONAL EXPERIENCE

SUPERVISION OF POSTGRADUATE STUDENTS

• Formulation of Surface Functionalized Hyaluronic Acid Coated Chitosan Nanoparticles for Chloroquine Delivery in Triple Negative Breast Cancer; A multifunctional Drug Delivery Approach
• Enhanced Targeted Treatment of Cervical Cancer Using Nanoparticle-Based Doxycycline Delivery System
• Unveiling the Therapeutic Potential of Lapatinib Nanoparticles in Arthritis Management
• Evaluation of the antioxidant, anti-inflammatory, and anti-spasmodic potential of coumarin in cyclophosphamide-induced cystitis
• Evaluation of anticancer effect of ketoprofen against chemically induced breast cancer
• Evaluation of pharmacological potential of terbinafine in a chemically induced hepatocellular carcinoma model
• In silico and experimental targeting of the Wnt/β-Catenin pathway by phytochemicals for colorectal cancer therapy
• Evaluation of therapeutic potential and mechanistic pathways of piroxicam in DMBA-Induced breast cancer
• Formulation and Evaluation of Chitosan-Based Nanoparticles Encapsulating Ovalbumin (OVA) as a Model Vaccine Antigen for Improved Thermal Stability
• Physicochemical Characterization, In Silico Prediction, and In Vitro, In Vivo (Subcutaneous) Evaluation of Electrophoretically Deposited Azadirachtin-Loaded Chitosan Coatings for Biocompatible Implant Applications

BOOK CHAPTERS

1. Wheat genomics and breeding: bridging the gap
2. Cutting-Edge Innovations in Viral Nanoformulations for Targeted Drug Delivery
3. Unleashing the Power of Oncolytic Viruses: Revolutionizing Prostate Cancer Therapy
4. Epigenetic influences of the gut microbiome: a new frontier in medicine
5. Standardization and quality control in microbiome analysis
6. Nutritional Epigenetics: Food-Derived microRNAs in Health and Disease
7. Smart Precision: Digital Twin and Smart Aquaculture

RESEARCH PUBLICATIONS 

1. Anti-arthritic potential of Pyrazoline derivative against Complete Freund’s Adjuvant Induced Arthritis in rats (2026).
2. Dose‐Dependent Toxicological Effects of Polyvinyl Chloride and Polystyrene Microplastics on Wistar Albino Rats (2026).
3. Genetic landscape and therapeutic evolution of cyclophosphamide: spotlight on breast cancer (2025).
4. A comparative analysis of Fagonia indica extracts and green synthesized nanoparticles for the determination of antioxidant potential (2025).
5. Surface Functionalized Hyaluronic Acid Coated Chitosan Nanoparticles for Enhanced Chloroquine Delivery in Triple-Negative Breast Cancer (2025).
6. Therapeutic Potential of Conyza bonariensis n‐Hexane Extract in Non‐Alcoholic Fatty Liver Disease: Histological, Biochemical, and In Silico Insights From a High (2025).
7. Exploring the anti-inflammatory effects of phytochemicals in attenuating interstitial cystitis-a literature review (2025).
8. Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery system (2025).
9. Traditional uses, botanical description, phytochemistry, and pharmacological activities of Phytolacca acinosa: a review (2025).
10. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast (2024).
11. Co‐delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro‐chemotherapeutic approach (2024).
12. Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma (2024).
13. Exploring plant-based dengue therapeutics: from laboratory to clinic (2024).
14. From cytokines to chemokines: Understanding inflammatory signaling in bacterial meningitis (2024).
15. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach. Frontiers in Immunology (2023).
16. Formulation of surface-functionalized hyaluronic acid-coated thiolated chitosan nanoformulation for delivering vincristine in prostate cancer. Journal of Drug Delivery Science and Technology, 74, 103545 (2022).
17. Green nanoparticles as multifunctional nanomedicines: Insights into anti-inflammatory effects, growth signaling and apoptosis mechanism in cancer. Seminars in Cancer Biology (2022).
18. Immune Landscape and Immunotherapy Options in Cervical Carcinoma. Cancers (MDPI), 14(18), 4458 (2022).
19. Serendipity for the intervention of COVID-19 and prostatic adenocarcinoma (PaC). Prostate Cancer and Prostatic Diseases, 25(1), 123-125 (2022).
20. Advanced therapeutic options for treatment of metastatic castration resistant prostatic adenocarcinoma. Frontiers in Pharmacology, 12, 6 (2021).
21. Genetic Predisposition and Chemotherapeutic Approaches Including Oncolytic Virus for the Treatment of Prostatic Adenocarcinoma. Preprints (2021).
22. Emerging role of chondroitin sulfate-based nanocarriers in improving the therapeutic outcome of NSAIDs in the treatment of osteoarthritis through the TDDDS. Journal of Shifa Tameer-e-Millat University, 4(1), 55-65 (2021).
23. Pathogenesis of COVID-19 associated with organ-based comorbidities. Journal of Shifa Tameer-e-Millat University, 3(2), 128-131 (2020).
24. Epigenetic modification in the expression of p73 p73-epigenetic target for anticancer therapy. Oncology Reviews, 13(2) (2019).
25. Stress: A Key Player for the Induction of Many Diseases. J Psychiatry Psychiatr Disord, 3(02), 37-56 (2019).
26. Antibacterial Activity of Medicinal Plants (Clove, Cinnamon, Garlic) Extracts and their Combined Effect with Antibiotics in Urinary Tract Infection Caused by Escherichia coli. Journal of Pharmaceutical Research Science & Technology, 2(2) (2018).
27. Preparation of magnetic microgels for catalytic reduction of 4-nitrophenol and removal of methylene blue from aqueous medium. International Journal of Environmental Science and Technology, 15(4), 863-874 (2018).
28. Phenotypic confirmatory disc diffusion test (PCDDT), double disc synergy test (DDST), Etest OS diagnostic tool for detection of extended spectrum beta lactamase. J Appl Biotechnol Bioeng, 3(3), 344-349 (2017).
29. Therapeutic Effects of Albendazole on Kidney Functions and Urinary Excretion of Florfenicol in Goats. Journal of Biomedical Sciences, 6(1) (2017).
30. Determination of caffeine in soft and energy drinks available in market by using UV/visible spectrophotometer. Family Medicine & Medical Science Research, 5(4), 1000206 (2016).
31. Comparative study of Causative agents of UTI among Indoor, outdoor, Children and Adult Patients of Pakistani Population. Bull. Env. Pharmacol. Life Sci, 5(8), 34-41 (2016).
32. HPLC analysis and Screening of aqueous Methanolic extract of Callistemon viminalis leaves against Gentamicin induced Nephrotoxicity. Bulletin of Environment, Pharmacology and Life Sciences, 5(9), 73-79 (2016).
33. Evaluation of hepatoprotective effect of chloroform and methanol extracts of Opuntia monacantha in paracetamol-induced hepatotoxicity in rabbits. Bangladesh Journal of Pharmacology, 10(1), 16-20 (2015).
34. Production of proteases by genetically improved Bacillus subtilis for enhanced skin penetration of antibacterial topical formulation. J. Biotechnol. Biomater, 5(2), 110 (2015).
35. In vivo cytotoxic effects of methanol extract of Convolvulus arvensis on 7-12-dimethyl benz (a) anthracene (DMBA) induced skin carcinogenesis. African Journal of Pharmacy and Pharmacology, 9(12), 397-404 (2015).
36. Cytotoxic effect of methanol extract of Conyza bonariensis on DMBA-induced skin carcinogenesis: An in vivo study. Bangladesh Journal of Pharmacology, 10(2), 467-74 (2015).
37. Hepatoprotective activity of Sonchus asper in paracetamol-induced hepatic damage in rabbits. Bangladesh Journal of Pharmacology, 10(1), 115-115 (2015).
38. Dengue: An escalating problem of our society. Open Journal of Epidemiology, 5(01), 9 (2015).
39. Antioxidant Potential of Leaves of Opuntia monacantha Ethanol Extract and Various Fractions: An in vitro Study. Global Journal of Pharmacology, 9(2), 144-149 (2015).
40. Antioxidant Potential of Leaves of Opuntia monacantha Ethanol Extract and its Fractions: An In vitro Study. Global Journal of Pharmacology, 9(1), 81-86 (2015).
41. Medicinal plants in the protection and treatment of liver diseases. Bangladesh Journal of Pharmacology, 9(4), 511-26 (2014).
42. Anticancer activity of n-hexane extract of Cichorium intybus on lymphoblastic leukemia cells (Jurkat cells). Afr. J. Plant Sci, 8, 315-319 (2014).
43. Cytotoxic effect of ethanol extract of Convolvulus arvensis L (Convolvulaceae) on lymphoblastic leukemia Jurkat cells. Tropical Journal of Pharmaceutical Research, 13(5), 705-709 (2014).
44. Hepatoprotective activity of ethanol extract of Conyza bonariensis against paracetamol induced hepatotoxicity in swiss albino mice. American Journal of Medical and Biological Research, 2(6), 124-127 (2014).
45. Anticancer Effect of Ethanolic Extract of Convolvulus arvensis on Lymphoblastic Leukemia Jurkat Cells. International Journal of Pharmacy and Integrated Life Sciences (2014).